TY - JOUR
T1 - Methyl Effect in Azumamides Provides Insight Into Histone Deacetylase Inhibition by Macrocycles
AU - Maolanon, Alex
AU - Villadsen, Jesper
AU - Christensen, Niels Johan
AU - Hoeck, Casper
AU - Friis, Tina
AU - Harris, Pernille
AU - Gotfredsen, Charlotte Held
AU - Fristrup, Peter
AU - Olsen, Christian Adam
PY - 2014
Y1 - 2014
N2 - Natural, nonribosomal cyclotetrapeptides have
traditionally been a rich source of inspiration for design of
potent histone deacetylase (HDAC) inhibitors. We recently
disclosed the total synthesis and full HDAC pro
fi
ling of the
naturally occurring azumamides (
J. Med. Chem.
2013
,
56
,
6512). In this work, we investigate the structural requirements
for potent HDAC inhibition by macrocyclic peptides using the
azumamides along with a series of unnatural analogues
obtained through chemical synthesis. By solving solution
NMR structures of selected macrocycles and combining these
fi
ndings with molecular modeling, we pinpoint crucial enzyme
−
ligand interactions required for potent inhibition of HDAC3.
Docking of additional natural products con
fi
rmed these features to be generally important. Combined with the structural
conservation across HDACs 1
−
3, this suggests that while cyclotetrapeptides have provided potent and class-selective HDAC
inhibitors, it will be challenging to distinguish between the three major class I deacetylases using these chemotypes.
AB - Natural, nonribosomal cyclotetrapeptides have
traditionally been a rich source of inspiration for design of
potent histone deacetylase (HDAC) inhibitors. We recently
disclosed the total synthesis and full HDAC pro
fi
ling of the
naturally occurring azumamides (
J. Med. Chem.
2013
,
56
,
6512). In this work, we investigate the structural requirements
for potent HDAC inhibition by macrocyclic peptides using the
azumamides along with a series of unnatural analogues
obtained through chemical synthesis. By solving solution
NMR structures of selected macrocycles and combining these
fi
ndings with molecular modeling, we pinpoint crucial enzyme
−
ligand interactions required for potent inhibition of HDAC3.
Docking of additional natural products con
fi
rmed these features to be generally important. Combined with the structural
conservation across HDACs 1
−
3, this suggests that while cyclotetrapeptides have provided potent and class-selective HDAC
inhibitors, it will be challenging to distinguish between the three major class I deacetylases using these chemotypes.
U2 - 10.1021/jm501399d
DO - 10.1021/jm501399d
M3 - Journal article
C2 - 25380299
SN - 0022-2623
VL - 57
SP - 9644
EP - 9657
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 22
ER -